Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice

Maas, M. (Monique); Beets-Tan, R. (Regina); Gaubert, J.Y. (Jean-Yves); Gómez-Muñoz, F. (Fernando); Habert, P. (Paul); Klompenhouwer, L.G. (Lisa G.); Vilares-Morgado, P. (Paulo); Schaefer, N. (Niklaus); Cornelis, F.H. (Francois H.); Solomon, S.B. (Stephen B.); van-der-Reijd, D. (Denise); Bilbao, J.I. (José I.)

Keywords:

Recommendations
Interventional radiology
Oncology
Liver
Lung cancer

Issue Date:

2020

ISSN:

1869-4101

Editorial note:

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Note:

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Citation:

Maas, M. (Monique); Beets-Tan, R. (Regina); Gaubert, J.Y. (Jean-Yves); et al. "Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice". Insights into Imaging. 11 (83), 2020,

Abstract

Interventional radiology plays an important and increasing role in cancer treatment. Follow-up is important to be able to assess treatment success and detect locoregional and distant recurrence and recommendations for follow-up are needed. At ECIO 2018, a joint ECIO-ESOI session was organized to establish follow-up recommendations for oncologic intervention in liver, renal, and lung cancer. Treatments included thermal ablation, TACE, and TARE. In total five topics were evaluated: ablation in colorectal liver metastases (CRLM), TARE in CRLM, TACE and TARE in HCC, ablation in renal cancer, and ablation in lung cancer. Evaluated modalities were FDG-PET-CT, CT, MRI, and (contrast-enhanced) ultrasound. Prior to the session, five experts were selected and performed a systematic review and presented statements, which were voted on in a telephone conference prior to the meeting by all panelists. These statements were presented and discussed at the ECIO-ESOI session at ECIO 2018. This paper presents the recommendations that followed from these initiatives. Based on expert opinions and the available evidence, follow-up schedules were proposed for liver cancer, renal cancer, and lung cancer. FDG-PET-CT, CT, and MRI are the recommended modalities, but one should beware of false-positive signs of residual tumor or recurrence due to inflammation early after the intervention. There is a need for prospective preferably multicenter studies to validate new techniques and new response criteria. This paper presents recommendations that can be used in clinical practice to perform the follow-up of patients with liver, lung, and renal cancer who were treated with interventional locoregional therapies.

URI:

https://hdl.handle.net/10171/66295

DOI:

10.1186/s13244-020-00884-5

Appears in Collections:

DA - CUN - Radiología - Artículos de revista

Files in This Item: